These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34991944)

  • 1. An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA.
    Wijburg FA; Aiach K; Chakrapani A; Eisengart JB; Giugliani R; Héron B; Muschol N; O'Neill C; Olivier S; Parker S
    Mol Genet Metab; 2022 Feb; 135(2):133-142. PubMed ID: 34991944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability change across multiple domains in mucopolysaccharidosis (Sanfilippo syndrome) type IIIA.
    Shapiro EG; Eisengart JB; Whiteman D; Whitley CB
    Mol Genet Metab; 2024 Feb; 141(2):108110. PubMed ID: 38151384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group.
    Köhn AF; Grigull L; du Moulin M; Kabisch S; Ammer L; Rudolph C; Muschol NM
    Mol Genet Metab Rep; 2020 Jun; 23():100578. PubMed ID: 32226768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design.
    Truxal KV; Fu H; McCarty DM; McNally KA; Kunkler KL; Zumberge NA; Martin L; Aylward SC; Alfano LN; Berry KM; Lowes LP; Corridore M; McKee C; McBride KL; Flanigan KM
    Mol Genet Metab; 2016 Nov; 119(3):239-248. PubMed ID: 27590925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II.
    Yee KS; Wu Y; Harrington M; Waisbren SE
    Orphanet J Rare Dis; 2021 Dec; 16(1):501. PubMed ID: 34863240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study.
    Muenzer J; Burton BK; Amartino HM; Harmatz PR; Gutiérrez-Solana LG; Ruiz-Garcia M; Wu Y; Merberg D; Alexanderian D; Jones SA
    Orphanet J Rare Dis; 2023 Nov; 18(1):357. PubMed ID: 37974184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.
    Shapiro EG; Nestrasil I; Delaney KA; Rudser K; Kovac V; Nair N; Richard CW; Haslett P; Whitley CB
    J Pediatr; 2016 Mar; 170():278-87.e1-4. PubMed ID: 26787381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A).
    Meyer A; Kossow K; Gal A; Mühlhausen C; Ullrich K; Braulke T; Muschol N
    Pediatrics; 2007 Nov; 120(5):e1255-61. PubMed ID: 17938166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
    Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
    Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B.
    Whitley CB; Cleary M; Eugen Mengel K; Harmatz P; Shapiro E; Nestrasil I; Haslett P; Whiteman D; Alexanderian D
    J Pediatr; 2018 Jun; 197():198-206.e2. PubMed ID: 29661560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter open-label extension study of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A.
    Wijburg FA; Whitley CB; Muenzer J; Gasperini S; Del Toro M; Muschol N; Cleary M; Sevin C; Shapiro E; Alexanderian D
    Mol Genet Metab; 2021; 134(1-2):175-181. PubMed ID: 34247932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of neurocognition in MPS disorders: A review.
    Shapiro EG; Eisengart JB
    Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding disease symptoms and impacts and producing qualitatively-derived severity stages for MPS IIIA: a mixed methods approach.
    Lanar S; Parker S; O'Neill C; Marrel A; Arnould B; Héron B; Muschol N; Wijburg FA; Chakrapani A; Olivier S; Aiach K
    Orphanet J Rare Dis; 2022 Feb; 17(1):75. PubMed ID: 35193633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations.
    Gentile JK; Tan WH; Horowitz LT; Bacino CA; Skinner SA; Barbieri-Welge R; Bauer-Carlin A; Beaudet AL; Bichell TJ; Lee HS; Sahoo T; Waisbren SE; Bird LM; Peters SU
    J Dev Behav Pediatr; 2010 Sep; 31(7):592-601. PubMed ID: 20729760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of an eye gaze AAC communication board by a young adult with advanced Sanfilippo Syndrome (MPS IIIA): Case report.
    Brennan C; Matthews A; Tennant S
    Ther Adv Rare Dis; 2024; 5():26330040241275672. PubMed ID: 39228859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).
    Meyer A; Kossow K; Gal A; Steglich C; Mühlhausen C; Ullrich K; Braulke T; Muschol N
    Hum Mutat; 2008 May; 29(5):770. PubMed ID: 18407553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and clinical outcomes of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A.
    Wijburg FA; Heap F; Rust S; de Ruijter J; Tump E; Marchal JP; Nestrasil I; Shapiro E; Jones SA; Alexanderian D
    Mol Genet Metab; 2021 Dec; 134(4):317-322. PubMed ID: 34600820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of Sanfilippo syndrome type A.
    Buhrman D; Thakkar K; Poe M; Escolar ML
    J Inherit Metab Dis; 2014 May; 37(3):431-7. PubMed ID: 24271936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients.
    Kong W; Meng Y; Zou L; Yang G; Wang J; Shi X
    J Pediatr Endocrinol Metab; 2020 May; 33(6):793-802. PubMed ID: 32447333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
    Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
    Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.